C0220825||Assessment
C0087111||Treatment
C0006107||Concussion
C0271379||convergence insufficiency
C0031928||Pilot Study
C0220825||evaluate
C0150177||office-based vision therapy
C0150177||office-based vision therapy
C0006107||concussion
C0271379||convergence insufficiency
C0271379||convergence insufficiency
C0015730||feasibility
C0220825||assessment
C0008976||clinical trial
C1518527||observational trial
C0679646||participants
C0332293||treated with
C0150177||office-based vision therapy
C0442519||home
C1283081||reinforcement
C0679646||Participants
C0006107||concussion
C0271379||convergence insufficiency
C0243095||peak velocity
C0332516||symmetrical
C0870533||convergence
C0243095||peak velocity
C0220825||evaluated
C0036019||saccadic eye movements
C3266594||clinical measures
C0423037||near point of convergence
C1514241||positive
C1302986||fusional vergence at near
C0282574||Convergence Insufficiency Symptom Survey
C0282574||Convergence Insufficiency Symptom Survey
C0220825||evaluated
C3266594||clinical measures
C0870533||convergence
C2349001||subjects
C0243095||peak velocity
C0332516||symmetrical
C0870533||convergence
C0443204||divergence
C0870533||convergence
C0036019||saccadic eye movements
C0150177||office-based vision therapy
C0087111||treatment
C0684224||report
C0006107||concussion
C0271379||convergence insufficiency
C0444454||accessible
C0022885||clinical tests
C0037088||clinical findings
C1457887||symptoms
C2603343||study
C0456984||results
C0006107||concussion
C0441516||demands
C0015413||eye movements
C0206034||randomized clinical trial
C0006107||concussion
C0271379||convergence insufficiency